TNF and neoplasm: Thus, anti-tumor immune response and prevention of neoplastic progression are mediated by cytokine control with anti-inflammatory therapy to reduce over-stimulated pro-inflammatory response, displayed by eicosanoids and cytokines, including TNF-α, and IL-644–46.